Back to Journals » International Journal of General Medicine » Volume 14

Long Non-Coding RNA HOTAIR Expression and Clinical Significance in Patients with Gestational Diabetes

Authors Su R, Wu X, Ke F

Received 24 September 2021

Accepted for publication 25 November 2021

Published 16 December 2021 Volume 2021:14 Pages 9945—9950

DOI https://doi.org/10.2147/IJGM.S341106

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser



Ruifen Su,* Xiaoli Wu,* Fengmei Ke

Department of Obstetrics and Gynecology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Fengmei Ke
Department of Obstetrics and Gynecology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, No. 158 Wuyang Avenue, Enshi, 445000, People’s Republic of China
Tel/Fax +86-7188222760
Email [email protected]

Purpose: The global incidence of gestational diabetes mellitus (GDM) is increasing year by year, and many studies have proved that long non-coding RNA (lncRNA) is involved in the regulation of GDM. The purpose of this study was to investigate the expression of HOTAIR in GDM patients and its clinical significance.
Patients and Methods: Ninety-eight healthy pregnant women and 99 pregnant women diagnosed with GDM were enrolled in this study. Blood samples were collected from all participants and used for qRT-PCR analysis to determine the serum HOTAIR levels. The ROC curve was constructed to evaluate the diagnostic value of HOTAIR for GDM. Pearson correlation coefficient was used to estimate the correlation between HOTAIR and clinical indicators of patients. Logistic regression analysis was performed to evaluate the independent predictors of GDM.
Results: The level of HOTAIR was augmented in GDM group compared with healthy controls. ROC curve revealed that HOTAIR as a diagnostic marker of GDM has high sensitivity and specificity. Pearson correlation coefficient showed that HOTAIR level was positively correlated with body mass index, fasting plasma glucose, 1-hour plasma glucose and 2-hour plasma glucose. Logistic regression analysis shows that HOTAIR is an independent factor of the occurrence of GDM.
Conclusion: The abnormal expression of HOTAIR in pregnant women with GDM made it a potential diagnostic biomarker for GDM.

Keywords: gestational diabetes mellitus, HOTAIR, diagnosis, biomarker

Introduction

Gestational diabetes mellitus (GDM) is an independent type of diabetes mellitus, which refers to the abnormal glucose tolerance of pregnant women or is first discovered during pregnancy, and it is one of the most common complications in the first and second stages of pregnancy.1,2 In China, the incidence of diabetes is rapidly rising, while the incidence of GDM is about 12.2%.3 During GDM, pregnant women will have abnormal blood glucose regulation, lipid metabolism, immune function and cardiopulmonary function to varying degrees,4 and may have pregnancy-related complications, such as pregnancy-related hypertension, eclampsia or abortion, premature birth, malformation.5 Although blood glucose level in patients with GDM usually returns to normal after delivery, in the long term, women with a history of GDM are more likely to develop type 2 diabetes,6 and their babies are more likely to be overweight or obese later in life.7 Therefore, prevention and early diagnosis of GDM are of great important to avoid adverse effects. In the past, scholars tried to identify and search for biomarkers of GDM, such as HbA1c8 and adiponectin.9 However, they were not effectively applied in clinical practice due to various reasons.

Long non-coding RNAs (lncRNAs) have attracted the attention of scholars under the current research background. LncRNAs are a class of functional RNA molecules with a length of more than 200 nucleotides, which regulate gene expression at the epigenetic, transcriptional and post-transcriptional levels and extensively participate in most processes of the organism growth.10,11 Numerous studies have proved that lncRNAs are involved in the occurrence and development of diseases, including cancer,12 cardiovascular disease,13 and autoimmune disease.14 LncRNA HOTAIR is located on chromosome 12q13, and it has been found to be abnormally expressed in various cancers.15 Existing studies have demonstrated that HOTAIR is elevated in the liver tissues of patients with type 2 diabetes mellitus (T2DM) and mice fed with a high-fat diet. In addition, the upregulation of HOTAIR promotes hepatic insulin resistance through the AKT/GSK pathway.16 Another study confirmed that levels of HOTAIR in PBMCs were significantly enhanced in patients with T2DM compared with normal glucose tolerance group.17 At present, the evidence has confirmed the association between HOTAIR and T2DM, but there are few studies on the correlation between HOTAIR and GDM.

In our study, blood samples were collected to measure the expression of HOTAIR in GDM and healthy pregnant women. In addition, we also studied the clinical diagnostic value of HOTAIR in GDM and evaluated the correlation between HOTAIR and clinical indicators as well as the occurrence of GDM.

Materials and Methods

Patients and Samples

A total of 197 pregnant women were enrolled in this study, among whom 99 were GDM patients, who were admitted to The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture between February 2020 and March 2021. The diagnosis of GDM is based on the GDM diagnostic guidelines formulated by the American Diabetes Association.18 Inclusion criteria: fasting blood-glucose ≥5.1 mmol/L. And/or oral glucose tolerance test (OGTT) with 1-hour blood-glucose ≥10.0 mmol/L, and/or 2-hour blood-glucose ≥8.5 mmol/L. Another 98 pregnant women were healthy and were defined as healthy controls. Exclusion criteria: Subjects with pregestational diabetes, abnormal liver function, severe infection, and malignant tumors were excluded from the study. All subjects underwent the same physical examination and OGTT examination. General information and clinicopathological indicators of the participants were recorded. Venous blood of each subject was collected, centrifuged and stored in the refrigerator at −80°C for further use. This study was conducted in accordance with the Declaration of Helsinki, and it has been approved by the Ethics Committee of The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, and all subjects have signed written informed consent.

qRT-PCR Analysis

Total RNAs in serum were extracted by TRIzol reagent (Invitrogen), and the reverse transcription of RNA was performed by SuperScript II Reverse Transcriptase kit (Invitrogen, USA) according to the manufacturer’s protocols. The amplification of cDNA was performed on the Applied Biosystems 7900 Real-Time PCR System using miScript SYBR® Green PCR kit (Qiagen GmbH, Germany). Amplification primers for qRT-PCR analysis are as follows: HOTAIR: (forward primer): 5ʹ-TCGCAGTGGAATGGAACGGA-3ʹ, (reverse primer): 5ʹ-GCGACCGGAGCTCATCTTAC-3ʹ. GAPDH: (forward primer): 5ʹ-CGCTGAGTACGTCGTGGAGT-3ʹ, (reverse primer): 5ʹ-TGTCATCATATCTGGCAGGT-3ʹ. Using GAPDH as internal reference, the relative expression level of HOTAIR was calculated by 2−ΔΔCt method.

Statistical Analysis

The differences between groups were analyzed by Student t-test or one-way ANOVA. ROC curve was used to evaluate the clinical diagnostic value of HOTAIR in GDM. Pearson correlation coefficient analyzed the correlation between HOTAIR expression and clinical indicators in GDM patients. Logistic regression was used to assess the relationship between different variables and the occurrence of GDM. Statistical analysis of this study was conducted using SPSS 17.0 software and GraphPad Prism 7 software. Data conforming to the normal distribution were expressed as mean ± SD. P < 0.05 was considered statistically significant.

Results

Comparison of Baseline Data

The baseline data and clinical indicators of participants are shown in Table 1. We could see that there were significant differences in body mass index (BMI), fasting plasma glucose (FBG), 1-hour plasma glucose, 2-hour plasma glucose, total cholesterol, and triglyceride between healthy pregnant women and pregnant women with GDM (P < 0.001). There were no significant differences in age, pregnancy, fetal birth weight and cholesterol between the two groups.

Table 1 Clinical Data of the Subject Population

Serum Level of HOTAIR in Pregnant Women with GDM

In this study, qRT-PCR was used to compare the expression levels of HOTAIR in serum of healthy pregnant women and pregnant women with GDM. The expression level of serum HOTAIR in pregnant women with GDM was augmented evidently in comparison to those healthy pregnant women (Figure 1, P < 0.001). We speculated that the abnormal expression of HOTAIR may play a role in GDM occurrence.

Figure 1 HOX transcript antisenseRNA (HOTAIR) expression was enhanced in pregnant women with gestational diabetes mellitus (GDM) (***P < 0.001).

ROC Analysis

ROC curve was used to analyze the diagnostic value of HOTAIR in GDM. Results indicated that the AUC value was 0.906 (Figure 2, sensitivity = 83.8%, specificity = 83.7%), suggesting that HOTAIR level had the ability to distinguish pregnant women with GDM and healthy pregnant women.

Figure 2 Receiver operating characteristic (ROC) curve was drawn to estimate the diagnostic significance of HOX transcript antisenseRNA (HOTAIR) in gestational diabetes mellitus (GDM).

Pearson Correlation Coefficient and Logistic Regression Analysis

Pearson correlation coefficient was performed to analyze the correlation between HOTAIR expression and clinicopathological indexes in pregnant women with GDM. As shown in Table 2, HOTAIR levels were significantly positively correlated with BMI, FBG, 1-hour plasma glucose and 2-hour plasma glucose levels (P < 0.01), which suggested that abnormal expression of HOTAIR was related to GDM and was also associated with the severity of GDM. In addition, logistics regression analysis was used to evaluate the relationship between different variables and the GDM occurrence. We found that HOTAIR (OR = 20.939, 95% CI = 9.415–46.567, P < 0.001) and BMI (OR = 2.999, 95% CI = 1.348–6.670, P = 0.007) were the independent influencing factors of GDM occurrence among many variables (Table 3).

Table 2 Correlation Between lncRNA HOTAIR and Clinical Characteristics

Table 3 Association of Different Variables with the Occurrence of Gestational Diabetes Mellitus

Discussion

Our study suggested that the expression of HOTAIR in pregnant women with GDM was significantly enhanced compared with that of healthy pregnant women, and that the abnormal expression of HOTAIR had higher clinical diagnostic value for GDM. Moreover, it was also found that HOTAIR level was positively correlated with the level of FBG and other indicators in pregnant women with GDM, which was an independent factor of the occurrence of GDM.

GDM is a disease that can cause serious complications for both a mother and her child.19 Timely prevention and treatment of GDM may help limit the long-term burden of the disease.20 Therefore, researchers are increasingly interested in finding new biomarkers with diagnostic, prognostic, and therapeutic effects in GDM. LncRNA plays a particularly important regulatory role in the growth, development, and metabolism of the organism. It has been well established that lncRNAs are involved in glucose metabolism, fat formation, and endocrine gland function.21 For example, lncRNA GAS5 can inhibit 6-phosphogluconase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK), which are the key enzymes in gluconeogenesis.22 Xu et al found that lncRNA SRA regulates adipogenesis through activation of insulin/IGF-1 signaling pathway.23 In our study, HOTAIR was upregulated in serum of pregnant women with GDM, and its expression level was positively correlated with BMI, plasma glucose and lipid levels of the patients. It was reported that HOTAIR was first discovered in human fibroblast HOX gene. Recent studies have shown that HOTAIR was highly expressed in adipose tissue, and in clinical sample analysis, circulating exosomes HOTAIR was higher in the obese group than in the lean group.24 The distribution of body fat has extensive repeatability with metabolic health, and obesity is closely related to the development of cardiovascular diseases and diabetes.25,26 Under these circumstances, we preliminarily speculated that the production of high levels of HOTAIR in GDM pregnant women may be indirectly attributable to unfriendly indicators such as BMI. Therefore, we conducted that the level of HOTAIR was closely related to the degree of obesity and the severity of GDM.

ROC curve indicated that HOTAIR levels in blood samples could be used as a factor to distinguish GDM pregnant women from healthy pregnant women. Unlike most protein biomarkers, lncRNAs are stable in blood circulation,27 and many previous studies have pointed out the important role of lncRNAs in the early diagnosis of diseases.28,29 Accordingly, our study preliminarily identified the potential of HOTAIR as a diagnostic biomarker for GDM diagnosis. Furthermore, logistic regression analysis exhibited that HOTAIR and BMI were independent factors of GDM, respectively. As far as BMI is concerned, the association between diabetes and obesity or overweight is self-evident.30 Obesity or overweight has been considered as an important risk factor for T2DM. T2DM will not only increase insulin resistance,31 but also aggravate metabolic abnormalities, including hyperglycemia, hyperlipidemia, and hyperinsulinemia.32 For HOTAIR, Shaker et al demonstrated that HOTAIR level was significantly enhanced in serum of diabetic retinopathy patients compared with non-diabetic retinopathy patients.33 According to reports, HOTAIR acts as a sponge molecule of miR-34 in diabetic cardiomyopathy, and aggravates the condition by promoting the expression of SIRT1.34 Malumder et al found that HOTAIR was expressed in both human and mouse renal tissues and increased in the kidneys of streptozotocin-induced diabetes mice and diabetic nephropathy patients.35 In the previously published studies listed above, the expression of HOTAIR was enhanced dramatically in both T2DM and diabetic-related diseases, and HOTAIR level in serum of pregnant women with GDM in this study was consistent with these results.

LncRNA can be used as miRNA sponge to regulate the disease progression by regulating the expression of target mRNA downstream of miRNA. For example, HOTAIR participated in promoting the progression of advanced gastric cancer by inhibiting the expression of HER2 through sponge miR-331-3p.36 At present, there are still relatively few studies on the mechanism of HOTAIR in GDM, and this study has not further explored the downstream target genes of HOTAIR based on the current data. However, in terms of the current experimental data, this study only made a preliminary analysis and explanation based on the expression of HOTAIR in the serum of pregnant women with GDM and healthy pregnant women. In order to improve the scientific and guiding significance of this study, we also need to determine whether the expression of HOTAIR in pregnant women’s placenta or amniotic fluid is consistent with that in blood, as well as the mechanism of HOTAIR in GDM, and verify our further results through in vitro or in vivo experiments. For these issues, we should put forward and develop solutions in the future related research.

Conclusion

In summary, the results of this study suggest that HOTAIR is upregulated in pregnant women with GDM, and the evaluation results of ROC curve indicate that HOTAIR is of high diagnostic value for GDM. In addition, HOTAIR proved to be an independent factor in the occurrence of GDM. Therefore, this study may provide evidence for finding new diagnostic markers in clinical application.

Ethics Statement

This study has been approved by the Ethics Committee of The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, and all subjects have signed written informed consent.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol. 2008;45(3):157–165. doi:10.1007/s00592-008-0037-8

2. Iliodromiti S, Sassarini J, Kelsey TW, Lindsay RS, Sattar N, Nelson SM. Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis. Diabetologia. 2016;59(4):692–699. doi:10.1007/s00125-015-3855-6

3. Qi S, Wang X. Decreased expression of miR-185 in serum and placenta of patients with gestational diabetes mellitus. Clin Lab. 2019;65(12). doi:10.7754/Clin.Lab.2019.190445

4. Poulsen H, Meurman JH, Kautiainen H, et al. Oral health in women with a history of high gestational diabetes risk. Dent J. 2019;7(3). doi:10.3390/dj7030092

5. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus–management guidelines. The Australasian diabetes in pregnancy society. Med J Aust. 1998;169(2):93. doi:10.5694/j.1326-5377.1998.tb140192.x

6. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–1779. doi:10.1016/S0140-6736(09)60731-5

7. Plasencia W, Garcia R, Pereira S, Akolekar R, Nicolaides KH. Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn Ther. 2011;30(2):108–115. doi:10.1159/000324684

8. Khalafallah A, Phuah E, Al-Barazan AM, et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016;6(4):e011059. doi:10.1136/bmjopen-2016-011059

9. Lain KY, Daftary AR, Ness RB, Roberts JM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol. 2008;69(3):407–411. doi:10.1111/j.1365-2265.2008.03198.x

10. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–669. doi:10.1534/genetics.112.146704

11. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914. doi:10.1016/j.molcel.2011.08.018

12. Chen R, Li WX, Sun Y, et al. Comprehensive analysis of lncRNA and mRNA expression profiles in lung cancer. Clin Lab. 2017;63(2):313–320. doi:10.7754/Clin.Lab.2016.160812

13. Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775. doi:10.1111/jcmm.13866

14. Lodde V, Murgia G, Simula ER, Steri M, Floris M, Idda ML. Long noncoding RNAs and circular RNAs in autoimmune diseases. Biomolecules. 2020;10(7). doi:10.3390/biom10071044

15. Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res. 2011;39(6):2119–2128. doi:10.1177/147323001103900608

16. Li M, Guo Y, Wang XJ, Duan BH, Li L. HOTAIR participates in hepatic insulin resistance via regulating SIRT1. Eur Rev Med Pharmacol Sci. 2018;22(22):7883–7890. doi:10.26355/eurrev_201811_16414

17. Sathishkumar C, Prabu P, Mohan V, Balasubramanyam M. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes. Hum Genomics. 2018;12(1):41. doi:10.1186/s40246-018-0173-3

18. Yu X, Liu Z, Fang J, Qi H. miR-96-5p: a potential diagnostic marker for gestational diabetes mellitus. Medicine. 2021;100(21):e25808. doi:10.1097/MD.0000000000025808

19. Radzicka S, Pietryga M, Iciek R, Brazert J. The role of visfatin in pathogenesis of gestational diabetes (GDM). Ginekol Pol. 2018;89(9):518–521. doi:10.5603/GP.a2018.0088

20. Filardi T, Panimolle F, Crescioli C, Lenzi A, Morano S. Gestational diabetes mellitus: the impact of carbohydrate quality in diet. Nutrients. 2019;11(7). doi:10.3390/nu11071549

21. Cheng H, Su JJ, Peng JY, et al. Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascade. J Asian Nat Prod Res. 2011;13(11):993–1002. doi:10.1080/10286020.2011.605062

22. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3(107):ra8. doi:10.1126/scisignal.2000568

23. Xu B, Gerin I, Miao H, et al. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS One. 2010;5(12):e14199. doi:10.1371/journal.pone.0014199

24. Lu X, Bai D, Liu X, Zhou C, Yang G. Sedentary lifestyle related exosomal release of Hotair from gluteal-femoral fat promotes intestinal cell proliferation. Sci Rep. 2017;7(1):45648. doi:10.1038/srep45648

25. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord. 2004;28(3):402–409. doi:10.1038/sj.ijo.0802567

26. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–1649. doi:10.1016/S0140-6736(05)67663-5

27. Jiang X, Lei R, Ning Q. Circulating long noncoding RNAs as novel biomarkers of human diseases. Biomark Med. 2016;10(7):757–769. doi:10.2217/bmm-2016-0039

28. Chao Y, Zhou D. lncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit. 2019;25:6581–6586. doi:10.12659/MSM.915100

29. Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20(22):5758.

30. Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002;15(Suppl 2):737–744.

31. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol. 1982;243(1):E15–E30. doi:10.1152/ajpendo.1982.243.1.E15

32. Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metab Clin North Am. 2003;32(4):805–22,viii. doi:10.1016/S0889-8529(03)00071-9

33. Shaker OG, Abdelaleem OO, Mahmoud RH, et al. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy. IUBMB Life. 2019;71(3):310–320. doi:10.1002/iub.1970

34. Lopez-Jimenez E, Rojas AM, Andres-Leon E. RNA sequencing and prediction tools for circular RNAs analysis. Adv Exp Med Biol. 2018;1087:17–33.

35. Majumder S, Hadden MJ, Thieme K, et al. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease. Diabetologia. 2019;62(11):2129–2142. doi:10.1007/s00125-019-4967-1

36. Wang JD, Zhou HS, Tu XX, et al. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML. Aging. 2019;11(10):3333–3347. doi:10.18632/aging.101985

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.